Previous studies have suggested that sex-related differences in the prognosis of COVID-19 patients may be associated with the difference in the expression of angiotensin-converting enzyme-2 (ACE-2), immune responses, comorbidities, socioeconomic factors, or environmental factors, such as smoking or alcohol consumption [6,7,8]. The gene discussed is ACE2; the disease is COVID-19.